Monday, January 23, 2023

Apples Healthy Choice

          Apples

Apples represent 12.5% of all consumed
Fruits in the world because of their health
Benefits ,taste .
Epidemiological studies suggest that a frequent
Apple intake is inversely associated with
Acute coronary syndrome ,total CVD mortality
And all cause mortality.
      All above advantages are behind the

Saying  an Apple a day keeps the doctor away.

Bioactive components  polyphenols include
Flavanols (catechin and proanthrocyanidins)
These may be responsible for potential 
Health effects. 

   Apples are an excellent source of polyphenols and fiber.

Apples consumption or their bioactive
Components is beneficial on lipid metabolism
And other markers of cardiovascular disease.

    The clinical trial was conducted (Ref1)
It was randomised controlled crossover 
Intervention trial. Apples use (Renetta Canada
2 daily for 8 weeks each separated by 4wk
Wash out period .) Apple control beverage
CV)
Results : Whole apple consumption decreased
Serum total cholesterol  5.89mmol/L: CB
 6.11mm/L :p=0.006
And LDL cholesterol (whole apple 
: 3.72mmol /L:CB 3.86mmol/L:p=0.031)
CB means control beverage.
Triacylglycerol (wA :1.17mmol/L:CB
 1.30 amol/L: p=0.021 )and 
Intercellular cell adhesion molecule -1
(WA:153.9ng/mL:CB :159.4ng/mL: p=0.028)
And increased serum uric acid
 (WA:341.4,Micromole /L  : CB:330 micro mol
/L: p=0.020 )
Compared with the CB  the response to endothelium dependent microvascular 
Vasodilation 
Was greater after the apples (WA:853
Perfusion units  (PU ),CB :760 PU ;p=0.037)
Than after CB .

     Apples had no effect on blood pressure
Or other  CVD markers.
Note:  WA : Whole Apple 
            CV : control beverage


Conclusions : These data support beneficial
Hypocholesterolemic and vascular effects
Of the daily consumption of 
proanthrocyanjdins rich apples by mildly
Hypercholesterolemic individuals.

Ref 1 Am J Clin Nutr 2020 Feb :111(2):307-318
       Athanasios Koutsos
     Samantha Riccadonna
  (.......)and Julie A Lovegrove

















No comments:

Post a Comment